Lifespan Cancer Institute at Rhode Island Hospital /ID# 168600 — Providence, Rhode Island

Lifespan Cancer Institute at Rhode Island Hospital /ID# 168600 is a clinical research site located in Providence, Rhode Island, United States 02903-4923.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Lifespan Cancer Institute at Rhode Island Hospital /ID# 168600 has participated in 1 clinical trials.

Therapeutic areas: Advanced Solid Tumors Cancer.

Sponsors: AbbVie.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Lifespan Cancer Institute at Rhode Island Hospital /ID# 168600?

Lifespan Cancer Institute at Rhode Island Hospital /ID# 168600 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Lifespan Cancer Institute at Rhode Island Hospital /ID# 168600 conducted?

Lifespan Cancer Institute at Rhode Island Hospital /ID# 168600 has 1 clinical trials on record. Their work covers Advanced Solid Tumors Cancer.

Is Lifespan Cancer Institute at Rhode Island Hospital /ID# 168600 accredited by Crixeo Health?

Lifespan Cancer Institute at Rhode Island Hospital /ID# 168600 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Lifespan Cancer Institute at Rhode Island Hospital /ID# 168600?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.